Exelixis EXEL
NASDAQ EXEL
$59.02 -0.11 (-0.19%)
As of: Sep 4, 2026 · 3:59 PM EDT

Exelixis (EXEL) Cost of Revenue (2013 - 2026)

Exelixis (EXEL) posted quarterly Cost of Revenue of $20.0 million for Q2 2026, up 4.07% year-over-year from $19.2 million in Q2 2025, and down 24.65% quarter-over-quarter from $26.5 million in Q1 2026.

Analysis

Exelixis (EXEL) Cost of Revenue (2013 - 2026) Analysis & Trends

Exelixis' Cost of Revenue history runs 14 years deep, the most recent figure standing at $20.0 million for Q2 2026.

  • In Q2 2026, Cost of Revenue rose 4.07% year-over-year to $20.0 million; the TTM figure through Apr 2026 stood at $84.5 million (up 13.96% YoY), while the FY2026 annual figure was $83.7 million, up 9.82% from the prior year.
  • Cost of Revenue for Q2 2026 stood at $20.0 million, down from $26.5 million in the prior quarter.
  • The five-year high for Cost of Revenue was $26.5 million in Q1 2026, with the low at $13.2 million in Q2 2022.
  • The 5-year median for Cost of Revenue is $18.6 million (2025), against an average of $18.3 million.
  • The sharpest annual moves came in 2024 and 2025: Cost of Revenue jumped 48.49% in 2024, then slipped 9.8% in 2025.
  • Exelixis' Cost of Revenue stood at $15.9 million in 2022, then jumped by 36.64% to $21.8 million in 2023, then dropped by 20.34% to $17.3 million in 2024, then advanced by 7.19% to $18.6 million in 2025, then climbed by 7.42% to $20.0 million in 2026.
  • Business Quant data shows EXEL's Cost of Revenue at $20.0 million in Q2 2026, $26.5 million in Q1 2026, and $18.6 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 489.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 360.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 145.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 93.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 174.53 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 298.26 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 67.21 Mn
10 Exelixis 14.81 Bn 13.97 Bn 608.03 Mn 20.66 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 3, 2026 20.66 Mn
Apr 3, 2026 19.95 Mn
Jan 2, 2026 26.48 Mn
Oct 3, 2025 18.57 Mn
Jul 4, 2025 19.47 Mn
Apr 4, 2025 19.17 Mn
Jan 3, 2025 19.97 Mn
Sep 27, 2024 17.33 Mn
Jun 28, 2024 17.67 Mn
Mar 29, 2024 21.26 Mn
Dec 29, 2023 21.75 Mn
Sep 29, 2023 18.77 Mn
Jun 30, 2023 17.71 Mn
Mar 31, 2023 14.32 Mn
Dec 30, 2022 15.92 Mn
Sep 30, 2022 15.31 Mn
Jul 1, 2022 13.48 Mn
Apr 1, 2022 13.20 Mn
Dec 31, 2021 12.92 Mn
Oct 1, 2021 11.87 Mn